Arovella Therapeutics Ltd has released a press release.
GM presentation
Filed with ASX ·
On 6ix: 6ix.com/news/gm-presentation
6ix hasn’t read this filing yet.
Arovella Therapeutics Limited on 6ix
In the deck
Earlier from Arovella Therapeutics
- Dr Reuben Benjamin Appointed to SUDA iNKT Cell Therapy SAB
- SUDA signs Licence and Distribution Agreement with STADA
- ZolpiMist Update
- iNKT cell therapy platform update
- SUDA appoints new cell and gene therapy manufacturing expert
Later from Arovella Therapeutics
- Chile Ministry of Health Approval Granted for ZolpiMist
- Arovella licences novel monoclonal antibody from MD Anderson
- AGM FY21 Presentation
- Arovella Completes $4.57M Placement & Launches $1.5M SPP
- SPP Offer Booklet
Follow Arovella Therapeutics into a list and get an email when it puts out news.
Follow Arovella Therapeutics